Traws Pharma, Inc. — Cash Flow Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Cash Flow
Cash Flow by Activity
Operating Cash Flow↓-22.9% -$1M
$-5M
Free Cash Flow
$0
Investing Cash Flow
$0
Financing Cash Flow↓-99.2% -$20M
$158K
Capex
$0
Stock-Based Comp↓-2.1% -$7K
$327K
Debt Issued
—
D&A↑+2100.0% +$42K
$44K
SBC Allocated Expense↓-2.1% -$7K
$327K